SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-04-000006
Filing Date
2004-03-24
Accepted
2004-03-24 16:08:27
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K r10k-031.txt 10-K 248920
3 SUBSIDIARIES r10k-032.txt EX-21 276
4 CONSENT OF INDEPENDENT CPA r10k-033.txt EX-23.1 769
5 CEO CERTIFICATION r10k-034.txt EX-31.1 3183
6 CFO CERITFICATION r10k-035.txt EX-31.2 3225
7 CEO CERTIFICATION r10k-036.txt EX-32.1 1474
8 CFO CERTIFICATION r10k-037.txt EX-32.2 1471
  Complete submission text file 0000318306-04-000006.txt   261724
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 04687504
SIC: 2834 Pharmaceutical Preparations